Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Geron reported $-38122000 in Net Income for its fiscal quarter ending in March of 2023.

Net Income Change
Amgen AMGN:US USD 2.84B 1.23B
Bio Techne TECH:US USD 70.22M 20.21M
CTI Biopharma CTIC:US USD -13422000 4.04M
Esperion Therapeutics ESPR:US USD -61719000 6.23M
Exelixis EXEL:US USD 40.03M 70.2M
Genmab GEN:DC DKK 226M 358M
Geron GERN:US USD -38122000 4.51M
Gilead Sciences GILD:US USD 1.01B 630M
Incyte Corp INCY:US USD 21.7M 6.76M
MacroGenics MGNX:US USD -38009000 50.81M
Novartis NOVN:VX USD 2.29B 827M
Novavax NVAX:US USD -293905000 111.66M
Seattle Genetics SGEN:US USD -174737000 26.57M